Skip to main content
SpringerLink
Log in

Dietary Antioxidants and Protection from Coronary Heart Disease

  • Chapter
Book cover Nutritional Health

Part of the book series: Nutrition ◊ and ◊ Health ((NH))

Abstract

This chapter discusses evidence linking antioxidant nutrients with the inhibition of low-density lipoprotein (LDL) oxidation. The possibility that increasing antioxidant intake could protect against coronary heart disease (CHD) is reviewed. The chapter also provides information regarding what ideal antioxidant intakes should be.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Witztum JL, Steinberg D. Role of oxidized LDL in atherogenesis. J Clin Invest 1991; 88: 1785–1792.

    Article  CAS  Google Scholar 

  2. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Ann Rev Biochem 1983; 52: 223–261.

    Article  CAS  Google Scholar 

  3. Steinbrecher UP, Lougheed M, Kwan WC, Dirks M. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. J Biol Chem 1989; 264:15, 216–15, 223.

    Google Scholar 

  4. Itabe H, Yamamoto H, Imanaka T, Shimamura K, Uchiyama H, Kimura J, et al. Sensitive detection of oxidatively modified low-density lipoprotein using a monoclonal antibody. J Lipid Res 1996; 37: 45–53.

    CAS  Google Scholar 

  5. Morel DW, DiCorleto PE, Chisholm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984; 4: 357–364.

    Article  CAS  Google Scholar 

  6. Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by the receptor for acetylated low density lipoproteins. Proc Natl Acad Sci USA 1981; 78: 6499–6503.

    Article  CAS  Google Scholar 

  7. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med 1992; 13: 341–390.

    Article  CAS  Google Scholar 

  8. Smith C, Mitchinson MJ, Aruoma OI, Halliwell B. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochem J 1992; 286: 901–905.

    CAS  Google Scholar 

  9. Heinecke JW. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr Opin Lipidol 1997; 8: 268–274.

    Article  CAS  Google Scholar 

  10. Quinn MT, Parthasarathy, S, Fong, LG, Steinberg, D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987; 84: 2995–2998.

    Article  CAS  Google Scholar 

  11. Navab M, Imes S, Hama S, Hough GP, Ross LA, Bork RW, et al. Monocyte transmigration induced by modifications of LDL in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein I synthesis and is abolished by HDL. J Clin Invest 1991; 88: 2039–2046.

    Article  CAS  Google Scholar 

  12. Hessler JR, Robertson AL, Chisolm GM. LDL cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cell culture. Atherosclerosis 1979; 32: 213.

    Article  CAS  Google Scholar 

  13. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelial-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990; 344: 160–162.

    Article  CAS  Google Scholar 

  14. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler R, Korpela H, Salonen R, Nyyssonen K, Palinski W, Witztum JL. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992; 339: 883–887.

    Article  CAS  Google Scholar 

  15. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991; 64: 5–15.

    CAS  Google Scholar 

  16. Witztum JL. Role of oxidized low-density lipoprotein in atherogenesis. Br Heart J 1993; 69: S12–S18.

    Article  Google Scholar 

  17. Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC. Socher SS, Butler SW, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989; 86: 1372–1376.

    Article  CAS  Google Scholar 

  18. Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S. Carew TE, Butler S, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989; 84: 1086–1095.

    Article  CAS  Google Scholar 

  19. Regnstrom J, Nilsson J, Tornvall P, Landon C, Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992: 339:1 183–1 186.

    Google Scholar 

  20. Ball, RY, Carpenter, KL, Mitchinson, MJ. What is the significance of ceroid in human atherosclerosis? Arch Pathol Lab Med 1987; I 1 1: 1134–1140.

    Google Scholar 

  21. Bhakdi S. An alternative hypothesis of the pathogenesis of atherosclerosis. Herz 1998; 23: 163–167.

    Article  CAS  Google Scholar 

  22. Torzewski M, Klouche M, Hock J. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in early atherosclerotic lesions. Atheroscler Thromb Vase Biol 1998; 18: 369–378.

    Article  CAS  Google Scholar 

  23. Gaziano JM, Manson, JE, Hennekens CH. Natural antioxidants and cardiovascular disease: observational epidemiologic studies and randomized trials. In: Frei B, ed. Natural Antioxidants in Human Health. Academic Press, Inc., San Diego, pp. 387–409.

    Google Scholar 

  24. Leake DS. Oxidised low density lipoproteins and atherogenesis. Br Heart J 1993; 69: 476–478.

    Article  CAS  Google Scholar 

  25. Frei B. Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation. Crit Rev Food Sci Nutr 1995; 35: 83–98.

    Article  CAS  Google Scholar 

  26. Duthie GG, Wahle KJ. Smoking, antioxidants, essential fatty acids and coronary heart disease. Biochem Soc Trans 1990; 18: 1051–1054.

    CAS  Google Scholar 

  27. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun 1989: 6: 67–75.

    Article  CAS  Google Scholar 

  28. Jessup, W, Rankin, SM, de Whalley, CV, Hoult, JRS, Scott, J. Leake, DS. Alpha-tocopherol consumption during low-density-lipoprotein oxidation. Biochem J 1990: 265: 399–405.

    CAS  Google Scholar 

  29. Stocker, R, Bowry, VW, Frei, B. Ubiquinol-l0 protects human low-density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci USA 1991; 88: 1646–1650.

    Article  CAS  Google Scholar 

  30. Esterbauer, H, Puhl, H, Dieber-Rotheneder, M, Waeg, G, Rabl, H. Effect of antioxidants on oxidative modification of LDL. Ann Med 1991; 23: 573–581.

    Article  CAS  Google Scholar 

  31. Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL. (1993) Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene. Arterioscler Thromb. 1993; 13: 590–600.

    Article  Google Scholar 

  32. Leonhardt, W, Hanefeld, M, Schaper, F. Diminished susceptibility to in vitro oxidation of low-density lipoprotein in hypercholesterolemia: key role of alpha-tocopherol content. Atherosclerosis 1999: 144: 103–107.

    Article  CAS  Google Scholar 

  33. Parthasarathy S, Khoo JC, Miller E, Barnett J, Witztum JL Steinberg D. (1990) Low density lipoprotein rich oleic acid is protected against oxidative modification: Implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci USA 1990: 87: 3894–3898.

    Article  Google Scholar 

  34. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 1992; 93: 189–199.

    Article  CAS  Google Scholar 

  35. Maxwell SRJ, Lip GYH. Free radicals and antioxidants in cardiovascular disease. Br J Clin Pharmacol 1997; 44: 307–317.

    Article  CAS  Google Scholar 

  36. Wiklund O, Mattson L, Bjoernheden T, Camejo G, Bondjiers G. Uptake and degradation of low-density lipoproteins in atherosclerotic rabbit aorta: role of local LDL modification. J Lipid Res 1991; 32: 55–62.

    CAS  Google Scholar 

  37. Kummerow FA, Mahfouz MM Zhou Q. (1999) Effects of antioxidants on atherogenesis. In: Basu TK, Temple NJ, Garg ML, eds. Antioxidants in Human Health and Disease. CABI, Oxon, pp. 165–173.

    Google Scholar 

  38. Singh RB, Niaz AM, Ghosh S, Agarwal P, Ahmad S, Begum R, et al. Randomized, controlled trial of antioxidant vitamins and cardioprotective diet on hyperlipidemia, oxidative stress and development of experimental atherosclerosis: the Diet and Antioxidant Trial on Atherosclerosis (DATA). Cardiovasc Drugs Ther 1995; 9: 763–771.

    Article  CAS  Google Scholar 

  39. Jialal I, Grundy SM. Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low-density lipoprotein. J Lipid Res 1992; 33: 899–906.

    CAS  Google Scholar 

  40. Suzukawa M, Ishikawa T, Yoshida H, Makamura H. Effect of in vivo supplementation with low-dose vitamin Eon susceptibility of low-density lipoprotein and high density lipoprotein to oxidative modification. J Am Coll Nutr 1995; 14: 46–52.

    CAS  Google Scholar 

  41. Princen HMG, van Duyvenvoorde W, Buytenhek R, van der Laarse A, van Poppel G, Leuven JAG, van Hinsberg VWM. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol 1995; 15: 325–333.

    Article  CAS  Google Scholar 

  42. Porkkala-Sarataho EK, Nyyssonen MK, Kaikkonen JE, Poulsen HE, Hayn EM, Salonen RM, Salonen JT. A randomized, single-blind, placebo-controlled trial of the effects of 200 mg atocopherol on the oxidation resistance of atherogenic lipoproteins. Am J Clin Nutr 1998; 68: 1034–1041.

    CAS  Google Scholar 

  43. Fuller CJ, Grundy SM, Norkus EP, Jialal I. Effect of ascorbate supplementation on low-density lipoprotein oxidation in smokers. Atherosclerosis 1996; 119: 139–150.

    Article  CAS  Google Scholar 

  44. Harats D, Chevion S, Nahir M, Norman Y, Sagee O, Berry EM. Citrus fruit supplementation reduces lipoprotein oxidation in young men ingesting a diet high in saturated fat: presumptive evidence for an interaction between vitamins C and E in vivo. Am J Clin Nutr 1998; 67: 240–245.

    CAS  Google Scholar 

  45. Jialal I, Norkus EP, Cristol L, Grundy SM. Beta-carotene inhibits the oxidative modification of low-density lipoprotein. Biochem Biophys Acta 1991; 1086: 134–138.

    Article  CAS  Google Scholar 

  46. Lin Y, Burri BJ, Neidlinger TR, Muller HG, Dueker SR, Clifford AJ. Estimating the concentration of (3-carotene required for maximal protection of low-density lipoproteins in women. Am J Clin Nutr 1998; 67: 837–845.

    CAS  Google Scholar 

  47. Jialal I, Grundy SM. Effect of combined supplementation with a-tocopherol, ascorbate and beta carotene on low-density lipoprotein oxidation. Circulation 1993; 88: 2780–2786.

    Article  CAS  Google Scholar 

  48. Woodside JV, Yarnell JWG, McMaster D, Young IS, Roxborough HE, McCrum EE, et al. Antioxidants, but not B-group vitamins increase the susceptibility of LDL to oxidation: a randomised, factorial design, placebo-controlled trial. Atherosclerosis 1999; 144: 419–427.

    Article  CAS  Google Scholar 

  49. Princen HMG, van Poppel G, Vogelezang C, Buytenhek R, Kok FJ. Supplementation with vitamin E but not beta-carotene in vivo protects low-density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking. Arterioscler Thromb 1992; 212: 554–562.

    Article  Google Scholar 

  50. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450–1456.

    CAS  Google Scholar 

  51. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med 1993; 328: 1444–1449.

    CAS  Google Scholar 

  52. Gey KG, Puska P, Jordan P, Moser UK. Inverse correlation between vitamin E and mortality from ischaemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991; 53: S326 - S334.

    Google Scholar 

  53. Riemersma RA, Wood DA, Maclntyre CCA, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 1991; 337: 1–5.

    Article  CAS  Google Scholar 

  54. Salonen JT, Salonen R, Seppanen K, Kantola M, Parviainen M, Alfthan G, et al. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men. Atherosclerosis 1988; 70: 155–160.

    Article  CAS  Google Scholar 

  55. Salonen JT, Salonen R, Penttila 1, Herranen J, Jauhianen M, Kantola M. et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol 1985; 56: 226–231.

    Article  CAS  Google Scholar 

  56. Kok FJ, de Bruijn AM, Vermeeren R, Hofman A, Vanlaar A, Debruin M, et al. Serum selenium, vitamin antioxidants. and cardiovascular disease mortality: a 9-year follow-up study in the Netherlands. Am J Clin Nutr 1987; 45: 462–468.

    CAS  Google Scholar 

  57. Hense HW, Stender M, Bors W, Keil U. Lack of association between serum vitamin E and myocardial infarction in a population with high vitamin E levels. Atherosclerosis 1993; 103: 21–28.

    CAS  Google Scholar 

  58. Street DA, Comstock GW, Salkeld RM, Schuep W, Klag M.I. Serum antioxidants and myocardial infarction. Circulation 1994; 90: 1154–1161.

    Article  CAS  Google Scholar 

  59. Manson JE, Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of vitamin C and incidence of coronary heart disease in women (Abstract). Circulation 1992; 85: 865.

    Google Scholar 

  60. Enstrom JE, Kanim LE. Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992; 3:194–202.

    Google Scholar 

  61. Kritchevsky, SB, Shimakawa, T, Tell, GS, Dennis, B, Carpenter, M, Eckfeldt, JH, et al. Dietary antioxidants and carotid artery wall thickness. The ARIC Study. Circulation 1995; 92: 2142–2150.

    Article  CAS  Google Scholar 

  62. Riemersma RA, Oliver M, Elton RA, Alfthan G, Vartiainen E, Salo M, et al. Plasma antioxidants and coronary heart disease: vitamins C, E, and selenium. Eur J Clin Nutr 1990; 44: 143–150.

    CAS  Google Scholar 

  63. Gey KF. Stahelin HB. Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischaemic heart disease and stroke: the Basle Prospective Study. Clin Invest 1993; 71: 3–6.

    Article  CAS  Google Scholar 

  64. Nyyssonen K, Parviainen MT, Salonen R, Tumilehto J, Salonen JT. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ 1997; 314: 634–638.

    Article  CAS  Google Scholar 

  65. Manson JE, Stampfer MJ, Willett WC, Colditz GA, Rosner B. Speizer FE, Hennekens CH. (1991) A prospective study of antioxidant vitamins and incidence of coronary heart disease in women (abstract). Circulation 84, 546.

    Google Scholar 

  66. Gaziano JM, Hennekens CH. (1993) The role of beta-carotene in the prevention of cardiovascular disease. Ann NY Acad Sci 691, 148–155.

    Article  CAS  Google Scholar 

  67. Gaziano JM, Manson JE, Branch LG, Colditz GA, Buring JE, Hennekens CH. (1992) A prospective study of beta-carotene in fruits and vegetables and decreased cardiovascular mortality in the elderly (Abstract). Am. J. Epidemiol. 136, 985.

    Google Scholar 

  68. Morris DL, Kritchevsky SB. Davis CE. Serum carotenoids and coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and follow-up study. JAMA 1994; 272: 1439–1441.

    Article  CAS  Google Scholar 

  69. Kardinaal AFM, Kok FJ, Ringstad J, Gomez-Aracena J, Mazaev VP, Kohlmeier L, et al. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study. Lancet 1993; 342: 1379–1384.

    Article  CAS  Google Scholar 

  70. Margetts BM, Jackson AA. Interactions between people’s diet and their smoking habits: the dietary and nutritional survey of British adults. BMJ 1993; 307: 1381–1384.

    Article  CAS  Google Scholar 

  71. Hennekens CH, Buring JE. Epidemiology in Medicine. Little, Brown and Co., Boston, 1987.

    Google Scholar 

  72. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029–1035.

    Google Scholar 

  73. Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, Heinonen OP. Randomised trial of a-tocopherol and 0-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997; 349: 1715–1720.

    Article  CAS  Google Scholar 

  74. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150–1155.

    Article  CAS  Google Scholar 

  75. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145–1149.

    Article  CAS  Google Scholar 

  76. Greenberg ER, Baron JA, Karagas MR, Stukel TA, Merenberg DW, Stevens MM, et al. Mortality associated with low plasma concentration of beta-carotene and the effect of oral supplementation. JAMA 1996; 275: 699–703.

    Article  CAS  Google Scholar 

  77. Hodis HN, Mack WJ, LaBrec L, Cashin-Hemphill L, Sevanian S, Johnson R, Azen SP. Serial coronary angiographic evidence that antioxidant vitamin intake reduced progression of coronary artery atherosclerosis. JAMA 1995; 273: 1849–1854.

    Article  CAS  Google Scholar 

  78. Singh RB, Niaz MA, Rastogi SS, Rastogi S. Usefulness of antioxidant vitamins in suspected acute myocardial infarction. Am J Cardiol 1996; 77: 232–236.

    Article  CAS  Google Scholar 

  79. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ, Brown MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781–786.

    CAS  Google Scholar 

  80. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447–455.

    Google Scholar 

  81. Greenberg ER, Sporn MB. Antioxidant vitamins, cancer, and cardiovascular disease. N Engl J Med 1996; 334: 1189–1190.

    Article  CAS  Google Scholar 

  82. Steinberg D. Clinical trials of antioxidants in atherosclerosis: are we doing the right thing? Lancet 1995; 346: 36–38.

    Article  CAS  Google Scholar 

  83. Riemersma RA. Coronary heart disease and vitamin E. Lancet 1996; 347: 776–777.

    Article  CAS  Google Scholar 

  84. Hennekens CH. Antioxidant vitamins and cardiovascular disease: current perspectives and future directions. Eur Heart J 1997; 18: 177–179.

    Article  CAS  Google Scholar 

  85. Slattery ML, Jacobs DR, Dyer A, Benson J, Hilmer JE, Caan BJ. Dietary antioxidants and plasma lipids: the CARDIA study. J Am Coll Nutr 1995; 14: 635–642.

    CAS  Google Scholar 

  86. Gregory J, Foster K, Tyler H, Wiseman M. The Dietary and Nutritional Survey of British Adults. London: HMSO, 1990.

    Google Scholar 

  87. Valkonen M, Kuusi T. Passive smoking induces atherogenic changes in low-density lipoprotein. Circulation 1998; 92: 2012–2016.

    Article  Google Scholar 

  88. Buring JE, Hennekens CH. The Women’s Health Study: Rational and background. J Myocardial Ischemia 1992; 4: 30–40.

    Google Scholar 

  89. Gaziano JM. Antioxidant vitamins and coronary artery disease risk. Am J Med 1994; 97: 3A - 18A.

    Article  Google Scholar 

  90. Sleight P. Can vitamins and cholesterol-lowering drugs help guard against heart disease? MRC News 1995; 66: 35–39.

    Google Scholar 

  91. Manson JE, Gaziano JM, Spelsberg A, Ridker PM, Cook NR, Buring JE, et al. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women: rationale design and methods. Ann Epidemiol 1995; 5: 261–269.

    Article  CAS  Google Scholar 

  92. HOPE Investigators. The HOPE (Heart Outcomes Prevention Evaluation) Study. The design of a large, simple randomised trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. Can J Cardiol 1995; 12: 127–137.

    Google Scholar 

  93. Thorogood M, Mann J, Appleby P, McPherson K. Risk of death from cancer and ischaemic heart disease in meat and non-meat eaters. BMJ 1994; 308: 1667–1671.

    Article  CAS  Google Scholar 

  94. Chang-Claude J, Frentzel-Beyme R, Eilber U. Mortality pattern of German vegetarians after 11 years of follow-up. Epidemiology 1992; 3: 395–401.

    Article  CAS  Google Scholar 

  95. Key T, Thorogood M, Appleby P, Burr M. Dietary habits and mortality in 11,000 vegetarians and health conscious people: results of a 17 year follow up. BMJ 1996; 313: 775–779.

    Article  CAS  Google Scholar 

  96. Phillips RL, Kuzma JW, Beeson WL, Lotz T. Influence of selection versus lifestyle on risk of fatal cancer and cardiovascular disease among Seventh-Day Adventists. Am. J. Epidemiol 1980; 112: 296–314.

    CAS  Google Scholar 

  97. Zino S, Skeaff M, Williams S, Mann J. Randomised controlled trial of effect of fruit and vegetable consumption on plasma concentrations of lipids and antioxidants. BMJ 1997; 314: 1787–1791.

    Article  CAS  Google Scholar 

  98. Singh RB, Rastogi SS, Niaz MA, Ghosh S, Singh R, Gupta S. Effect of fat-modified and fruit-enriched and vegetable-enriched diets and blood lipids in the Indian Diet Heart Study. Am J Cardiol 1992; 70: 869–874.

    Article  CAS  Google Scholar 

  99. Wise JA, Morin RJ, Sanderson R, Blum K. Changes in plasma carotenoid, alpha-tocopherol, and lipid peroxide levels in response to supplementation with concentrated fruit and vegetable extracts-a pilot study. Curr Ther Res Clin Exp 1996; 57: 445–461.

    Article  CAS  Google Scholar 

  100. Mangiapane H, Thompson J, Salter A, Brown S, Bell DG, White D. The inhibition of oxidation of low-density lipoprotein by catechin: a naturally occurring flavonoid. Biochem Pharmacol 1992; 43: 445–450.

    Article  CAS  Google Scholar 

  101. Hertog MGL, Feskens EJM, Holtman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease. The Zutphen Elderly Study. Lancet 1993; 342: 1007–1011.

    Article  CAS  Google Scholar 

  102. Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study Arch Int Med 1995: 55: 381–386.

    Google Scholar 

  103. Aviram M, Fuhrman B. Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis. Atherosclerosis 1998; 137: S45 - S50.

    Article  CAS  Google Scholar 

  104. Nigdikar SV, Williams NR, Griffin BA Howard AN. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am. J. Clin. Nutr. 1998; 68: 258–265.

    CAS  Google Scholar 

  105. Tikkanen Mi, Wahala K, Ojala S, Vihma V, Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci USA 1998; 95: 3106–3110.

    Article  Google Scholar 

  106. Kerry N, Abbey M. The isoflavone genistein inhibits copper and peroxyl radical mediated low density lipoprotein oxidation in vitro. Atherosclerosis 1998; 140: 341–347.

    Article  CAS  Google Scholar 

  107. Woodside JV, Denholm EE, Campbell Al, Young IS, Honour J, Leathern AJC. The effect of phyto-estrogen supplementation on antioxidant status. Proc Nutr Soc 2000; 59: 48A.

    Google Scholar 

  108. Munday JS, James KA, Fray LM, Kirkwood SW, Thompson KG. Daily supplementation with aged garlic extract, but not raw garlic, protects low density lipoprotein against in vitro oxidation. Atherosclerosis 1999; 143: 399–404.

    Article  CAS  Google Scholar 

  109. Stocker R, Bowry VW, Frei B. Ubiquino1–10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha tocopherol. Proc Natl Acad Sci USA 1991; 88: 1646–1650.

    Article  CAS  Google Scholar 

  110. Shwaery GT, Vita JA, Keaney JF. Antioxidant protection of LDL by physiologic concentrations of estrogens is specific for 17-beta-estradiol. Atherosclerosis 1998: 138: 255–262.

    Article  CAS  Google Scholar 

  111. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337: 408–416.

    Article  CAS  Google Scholar 

  112. Teupser D, Thiery J, Seidel D. a-Tocopherol down-regulates scavenger receptor activity in macrophages. Atherosclerosis 1999; 144: 109–115.

    Article  CAS  Google Scholar 

  113. Tasinato A, Boscoboinik D, Bartoli GM, Maroni P, Azzi A. D-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc Natl Acad Sci USA 1995; 92: 12190–12194.

    Article  CAS  Google Scholar 

  114. Hennig B, Enoch C, Chow CK. Protection by vitamin E against endothelial cell injury by linoleic acid hydroperoxides. Nutr Res 1987; 7: 1253–1260.

    Article  CAS  Google Scholar 

  115. Belcher JD, Balla J, Balla G. Vitamin E, LDL, and endothelium: brief oral supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arterioscler Thromb 1993; 13: 1779–1789.

    Article  CAS  Google Scholar 

  116. Plane F, Jacobs M, McManus D, Bruckdorfer KR. Probucol and other antioxidants prevent the inhibition of endothelium-dependent relaxation by low density lipoproteins. Atherosclerosis 1993; 103: 73–79.

    Article  CAS  Google Scholar 

  117. Anderson TJ, Meredith IT, Charbonneau F. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation 1996; 93: 1647–1650.

    Article  CAS  Google Scholar 

  118. US Department of Health and Human Services. Healthy People 2000: Draft for Public Comment. Government Printing Office, Washington DC, 1998.

    Google Scholar 

  119. Tippett KS, Cleveland LE. How current diets stack up: comparisons with dietary guidelines, In: Frazao E, Tippett KS, eds. America’s Eating Habits: Changes and Consequences. Agricultural Information Bulletin 750, Washington DC, 1999, pp. 51–70.

    Google Scholar 

  120. Block G, Sinha R, Gridley G. Collection of dietary-supplement data and implications for analysis. Am J Clin Nutr 1994; 59: 232S - 239S.

    CAS  Google Scholar 

  121. Gey KF. Ten-year retrospective on the antioxidant hypothesis of arteriosclerosis: threshold plasma levels of antioxidant micronutrients related to minimum cardiovascular risk. Nutr Biochem 1995; 6: 206–236.

    Article  CAS  Google Scholar 

  122. Can AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr 1999; 69: 1086–1107.

    Google Scholar 

  123. Steinberg GD, Parthasarthy S, Carew TE, Khooz JC, and Witztum JL. Beyond cholesterol—modification of low-density lipoprotein that increase its atherogenicity. N Eng J Med 1989, 915–924.

    Google Scholar 

Download references

Authors
  1. Jayne V. Woodside
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ian S. Young
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Exercise and Sport Science/Health Education, University of Wisconsin-La Crosse, La Crosse, WI, USA

    Ted Wilson PhD

  2. Centre for Science, Athabasca University, Athabasca, Alberta, Canada

    Norman J. Temple PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Woodside, J.V., Young, I.S. (2001). Dietary Antioxidants and Protection from Coronary Heart Disease. In: Wilson, T., Temple, N.J. (eds) Nutritional Health. Nutrition ◊ and ◊ Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-226-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-226-5_8

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-6054-5

  • Online ISBN: 978-1-59259-226-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation